Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production News

-Samsung BioLogics delisted from Korean Stock Exchange-No-deal prep a waste of time, Welsh ABPI says -Alabama insurer won't cover oxycontin -NICE say...
Swiss newspaper Tages-Anzeiger has reported that Novartis is preparing for a split with long-term partner Sandoz.
Novartis has declared new findings for Entresto, showing that the drug proved itself superior to enalapril-a in patients with heart failure with...
Public Health England is urging the public to ensure that they have received two doses of the MMR vaccine after it was revealed that there were...
A combination of chemotherapy drug azacitidine and nivolumab (Bristol-Myers Squibb’s Opdivo) has proven effective in treating patients with...
AstraZeneca has jettisoned another non-essential asset with the sale of Synagis (palivizumab), a preventative treatment for infections relating to...
Shares in Korean firm Samsung BioLogics plummeted this week, falling by as much as 20% on Monday, after the South Korean Securities and Futures...
Check out this week’s top ten most popular stories on Pharmafile.com!
Despite the threat of a bipartisan pricing plan, pharma stocks have soared after the announcement of the results of the US midterm elections.
The UK’s Business Secretary has announced the introduction of five specialist collaborative centres across the UK which with leverage advanced...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches